1. Home
  2. QTTB vs ZEUS Comparison

QTTB vs ZEUS Comparison

Compare QTTB & ZEUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTTB
  • ZEUS
  • Stock Information
  • Founded
  • QTTB 2015
  • ZEUS 1954
  • Country
  • QTTB United States
  • ZEUS United States
  • Employees
  • QTTB N/A
  • ZEUS N/A
  • Industry
  • QTTB Biotechnology: Pharmaceutical Preparations
  • ZEUS Metal Fabrications
  • Sector
  • QTTB Health Care
  • ZEUS Industrials
  • Exchange
  • QTTB Nasdaq
  • ZEUS Nasdaq
  • Market Cap
  • QTTB 434.0M
  • ZEUS 406.7M
  • IPO Year
  • QTTB N/A
  • ZEUS 1994
  • Fundamental
  • Price
  • QTTB $24.55
  • ZEUS $42.41
  • Analyst Decision
  • QTTB Strong Buy
  • ZEUS
  • Analyst Count
  • QTTB 6
  • ZEUS 0
  • Target Price
  • QTTB $72.33
  • ZEUS N/A
  • AVG Volume (30 Days)
  • QTTB 101.3K
  • ZEUS 109.9K
  • Earning Date
  • QTTB 11-07-2024
  • ZEUS 10-31-2024
  • Dividend Yield
  • QTTB N/A
  • ZEUS 1.43%
  • EPS Growth
  • QTTB N/A
  • ZEUS N/A
  • EPS
  • QTTB N/A
  • ZEUS 2.27
  • Revenue
  • QTTB N/A
  • ZEUS $2,012,296,000.00
  • Revenue This Year
  • QTTB N/A
  • ZEUS N/A
  • Revenue Next Year
  • QTTB N/A
  • ZEUS $6.46
  • P/E Ratio
  • QTTB N/A
  • ZEUS $18.47
  • Revenue Growth
  • QTTB N/A
  • ZEUS N/A
  • 52 Week Low
  • QTTB $9.18
  • ZEUS $32.23
  • 52 Week High
  • QTTB $53.79
  • ZEUS $73.49
  • Technical
  • Relative Strength Index (RSI)
  • QTTB 16.31
  • ZEUS 61.01
  • Support Level
  • QTTB $26.00
  • ZEUS $38.93
  • Resistance Level
  • QTTB $51.26
  • ZEUS $40.92
  • Average True Range (ATR)
  • QTTB 4.06
  • ZEUS 1.60
  • MACD
  • QTTB -2.11
  • ZEUS 0.27
  • Stochastic Oscillator
  • QTTB 2.38
  • ZEUS 96.33

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

About ZEUS Olympic Steel Inc.

Olympic Steel Inc provides metals processing and distribution services in the United States. The company operates in three reportable segments; specialty metals flat products, carbon flat products, and tubular and pipe products. It specializes in the processing and distribution of large volumes of carbon, aluminum, and stainless steel flat-rolled sheet, coils, plates, bars, and fabricated parts. The group serves various industries such as industrial machinery and equipment manufacturers, automobile manufacturers and suppliers, and transportation equipment manufacturers. The company generates majority of the revenue from carbon flat products.

Share on Social Networks: